Mirum Pharmaceuticals, Inc. (MIRM)
Market Open
26 Oct, 06:09 PM
$
82. 75
+2.36
+2.9419%
$
5.22B Market Cap
- P/E Ratio
- Div Yield
9,476 Volume
-3.47 Eps
$ 80.39
Previous Close 
Want to track MIRM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Mirum Pharmaceuticals, Inc. (MIRM) Statistics
Valuation metrics
Market Cap 5.22B
Enterprise value 5.65B
Trailing P/E (ttm) -5.52
Forward P/E -176.74
PEG ratio 0
Price/Sales (ttm) 8.45
Price/Book (mrq) -488.84
Enterprise Value/Revenue 9.14
Enterprise Value/EBITDA -7.27
Overview
Shares outstanding 60.93M
Float 52.48M
Shares short 8.41M
% Held by insiders 0.01%
% Held by institutions 1.15%
Average volume (10 days) 618.8K
Average volume (90 days) 722.08K
Price summary
52-Week low 63.23
52-Week high 130
Beta 0.52
50-Day moving average 88.2
200-Day moving average 100.11
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -1.39%
Operating margin -0.17%
Operational effectiveness
Return on assets -0.82%
Return on equity -4.1%
Income Statement
Revenue (ttm) 569.61M
Revenue per share (ttm) 9.75
Quarterly revenue growth (yoy) 0.43%
Gross profit (ttm) 463.58M
EBITDA 17.21M
Net income to common (ttm) -798.84M
Diluted EPS (ttm) -13.57
Quarterly earnings growth (yoy) 0.43%
Balance Sheet
Total cash (mrq) 386.26M
Total cash per share (mrq) 6.92
Total debt (mrq) 323.78M
Total Debt/Equity (mrq) -72.97
Current ratio (mrq) 2.86%
Book value per share (mrq) -0.16
Cash Flow
Cash flow statement -170.98M
Levered free cash flow (LFCF) 166.9M
2026 © Marketlog. All Rights Reserved.
